StanfordBiotechGroup
@stanfordbiotech
Our mission is to help Stanford University students explore career opportunities, build industry connections, and promote diversity and inclusion in biotech.
ID: 3072056083
http://www.stanfordbiotechgroup.com 10-03-2015 22:15:45
98 Tweet
781 Followers
107 Following
Interested in founding an impactful company or how VCs support founders on that journey? Join Stanford Biotech Group and Fifty Years on Thurs. 11/17 at 6pm for a panel discussion on impact VC and company creation. Food and drinks provided! RSVP here: tinyurl.com/35bmw8hs
Thank you Vincent Boudreau for speaking at our #AgBiotech Innovation Seminar Series hosted by Carnegie Science and StanfordBiotechGroup. #CarbonDrop has an inspiring solution for dropping #carbon deep down into the ocean. Thank you @nedafakhimi1 and #JasonThomas for co-organizing.
🧬💻 Interested in learning about the intersection of Tech x Biology? Join us on Jan 25th from 5-6pm at Stanford for a discussion with Vasudev Bailey, Senior Partner at ARTIS Ventures. RSVP for location tinyurl.com/techbio23 Vasudev Bailey, PhD Artis Ventures
As part of our Women Founder Series, join us on April 13th from 5-6pm for a discussion with Stanford alum and Interface Biosciences founder Dr. Hannah Hannah Wastyk. RSVP using this link for more details: tinyurl.com/hwast13
Join SBG and @StanfordBioE for a student founder snack and chat event on 4/25 at 6 pm! The event features Tim Schnabel of Switch Bioworks, Nicholas Hughes of Acrobat Genomics, and Hannah Wastyk of Interface Biosciences. RSVP here: forms.gle/roFKvFSzzxXdWR… Sponsored by R42 and @StanfordBioE
Join us for an event discussing the future of psychedelics on Apr. 20 at 6 pm featuring Matias Serebrinsky of @psymedventures and Boris D Heifets of Stanford Medicine! RSVP here for more details: tinyurl.com/SBG-psych
Check out the recent SBG blog post by Niraj Mehta, a Ph.D. student at Stanford, where he discusses the prescription drug shortage and how it came to be. stanfordbiotechgroup.com/insights/drug-…
Our blog post on Pillar VC, written by Stanford University Ph.D. student Logan Leak, is now LIVE. Check it out! stanfordbiotechgroup.com/insights/pilla…
Check out our recent interview with Shahram Seyedin-Noor, the founder and general partner of Civilization VC, a San Francisco-based venture capital fund focused entirely on biology and healthcare companies. Written by Logan Leak, a Ph.D. student at Stanford. stanfordbiotechgroup.com/insights/civil…
Check out Logan Leak's interview with Shahram Seyedin-Noor of Civilization VC where they talk all things biotech VC! Click below to hear about breaking into VC, finding your niche, and what makes for successful funds and startups. stanfordbiotechgroup.com/insights/civil…
Excited to team up with Valence Labs for a techbio meetup on April 22nd! Join us for a night of engaging discussions on AI + biomedicine! Don’t miss the chance to hear @brianhie deliver a keynote talk on Evo! Register at lu.ma/techbio
🧵1/6 We're so excited to announce the inaugural machine learning for drug discovery summer school! 🏫 What: Lectures from Yoshua Bengio, Anne Carpenter, PhD, @tiwarylab, Bharath Ramsundar, and more. 📍Where: Mila - Institut québécois d'IA 📅 When: June 12th - 21st Learn more here: portal.ml4dd.com
Interested in learning about a career transition from PhD scientist to patent lawyer? Check out our new blog post on Wilson Sonsini written by Logan Leak stanfordbiotechgroup.com/insights/wilso…
Ventyx's market value fell from $2.4 billion to $140 million due to disappointing data on ulcerative colitis and plaque psoriasis candidates, prompting the discontinuation of VTX958. Jason Akram discusses the rise and fall of Ventyx's VTX958 here! stanfordbiotechgroup.com/insights/venty…